New Statesman Spotlight will convene leaders from politics, business, and academia to discuss the future of biotechnology in Britain. This ambitious online series will examine the challenges and issues facing sector leaders, as well as the policy decisions that can support a thriving industry in post-Covid Britain.
Join the panel
Cambridge consultants Matthew Jones, principal synthetic biologist will be joining industry experts on a panel and live Q&A to discuss how UK industry is directly responsible for a quarter of the UK’s greenhouse gas emissions. But agricultural biotech could help reduce emissions and increase food security for a growing population, by creating products and processes based on renewables. How can we use biotechnology to take the UK towards net zero carbon? And can biotech be used to create a circular economy?
Using Biotechnology to Transition to Net Zero
Date | 15 July 2021
Time | 14:30 - 15:15 (BST)
- Matthew Jones, Principal Synthetic Biologist Cambridge Consultants
- Dr Martin Hayes, Biotechnology Lead, Johnson Matthey
- Professor Nigel Scrutton, University of Manchester
- Sonja van Renssen, Managing Editor, Energy Monitor
- Creating robust bioprocessing scale-down models [eBook]
- Let’s go! The new Catapult consortium is a brilliant boost for cell and gene therapy manufacturing [Insights]
- CATALOG DNA data encoding machine: Enabling the world's first DNA-based platform for massive data storage [Case Study]
- Bioinnovation: from research to commercialisation [Insights]
- Bioinnovation: Business success from world-changing science [expertise page]